The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes

BACKGROUND: In critically ill patients with permissive hyperglycemia, it is uncertain whether exogenous insulin administration suppresses or enhances c-peptide secretion (a marker of pancreatic beta-cell response). We aimed to explore this effect in patients with type 2 diabetes. METHODS: We prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Crisman, Marco, Lucchetta, Luca, Luethi, Nora, Cioccari, Luca, Lam, Que, Eastwood, Glenn M., Bellomo, Rinaldo, Mårtensson, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Paris 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427062/
https://www.ncbi.nlm.nih.gov/pubmed/28497374
http://dx.doi.org/10.1186/s13613-017-0274-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427062/
https://www.ncbi.nlm.nih.gov/pubmed/28497374
http://dx.doi.org/10.1186/s13613-017-0274-5

Ejemplares similares